APA (7th ed.) Citation

Zhang, Y., Xu, B., Shi, J., Li, J., Lu, X., Xu, L., . . . Craven, R. (2020). BRD4 modulates vulnerability of triple-negative breast cancer to targeting of integrin-dependent signaling pathways. Cellular Oncology (2211-3428), 43(6), 1049. https://doi.org/10.1007/s13402-020-00537-1

Chicago Style (17th ed.) Citation

Zhang, Yang, et al. "BRD4 Modulates Vulnerability of Triple-negative Breast Cancer to Targeting of Integrin-dependent Signaling Pathways." Cellular Oncology (2211-3428) 43, no. 6 (2020): 1049. https://doi.org/10.1007/s13402-020-00537-1.

MLA (9th ed.) Citation

Zhang, Yang, et al. "BRD4 Modulates Vulnerability of Triple-negative Breast Cancer to Targeting of Integrin-dependent Signaling Pathways." Cellular Oncology (2211-3428), vol. 43, no. 6, 2020, p. 1049, https://doi.org/10.1007/s13402-020-00537-1.